Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age18-40
SponsorAin Shams University

About this trial

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Eligibility criteria

Qualifiers

None

Disqualifiers

blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Trial design

Treatments tested in this trial

  • Plasma derived exosomes

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators